As of 2025-07-11, the Relative Valuation of Dicerna Pharmaceuticals Inc (DRNA) is (35.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on Relative Valuation is -194.0%.
The range of the Relative Valuation is (29.21) - (40.15) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 24.4x | 20.3x |
| Forward P/E multiples | 17.8x - 29.1x | 23.4x |
| Fair Price | (29.21) - (40.15) | (35.93) |
| Upside | -176.4% - -205.0% | -194.0% |
| Date | P/E |